MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03880 MEDTIDE

Not Yet Opened 09-25 15:59:08

22.780

-0.720

-3.06%

High23.700	Low21.000	Vol98.20K
Open23.300	D1 Closing23.500	Amplitude11.49%
Mkt Cap3.23B	Tradable Cap3.23B	Total Shares141.80M
T/O2.17M	T/O Rate0.07%	Tradable Shares141.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":22.78,"timestamp":1790323148123,"preClose":23.5,"halted":0,"volume":98200,"delay":0,"changeRate":-0.03063829787234038,"floatShares":141800000,"shares":141800000,"eps":1.9019245099500341,"marketStatus":"Not Yet Opened","change":-0.72,"latestTime":"09-25 15:59:08","open":23.3,"high":23.7,"low":21,"amount":2165396,"amplitude":0.114894,"askPrice":23.2,"askSize":1000,"bidPrice":21.28,"bidSize":200,"shortable":0,"etf":0,"ttmEps":1.3895962204381624,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":0,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":23.5,"openAndCloseTimeList":[[1790299800000,1790308800000],[1790312400000,1790323200000]],"volumeRatio":0.9743996837335975,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03880","defaultTab":"news","newsList":[{"id":"2669946178","title":"Medtide Says Li Lingmei Resigns as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2669946178","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669946178?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:20","pubTimestamp":1790245217,"startTime":"0","endTime":"0","summary":"BRIEF-Medtide Says Li Lingmei Resigns As Executive DirectorSept 24 (Reuters)-Medtide Inc.3880.HK:LI LINGMEI RESIGNS AS EXECUTIVE DIRECTOR EFFECTIVE SEPTEMBER 24, 2026Further company coverage:3880.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669687461","title":"Medtide Acquires China Land, Property for Peptide CDMO Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2669687461","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669687461?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:04","pubTimestamp":1790244246,"startTime":"0","endTime":"0","summary":"Medtide  completed the acquisition of a parcel of industrial land and property in Hangzhou City, China, a Thursday Hong Kong bourse filing said.The land and property are proposed to be used in phase I of the company's large-scale peptide and oligonucleotide CDMO production base project.The company plans to construct a large-scale peptide active pharmaceutical ingredients production line under the project with an estimated designed annual production capacity of 3 to 5 tonnes.Further expansion using an adjacent land parcel to develop a large-scale CDMO production park is also part of the company's plan.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SRU.SI","CDMO","CFA.SI","JJJ.SI","CLR.SI","BK1141","GLS.SI","03880","SRT.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194254391","title":"MEDTIDE Announces Executive Director Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=1194254391","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194254391?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:50","pubTimestamp":1790239813,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has issued an announcement stating that Ms. Li Lingmei has resigned from her position as an executive director due to personal work arrangements, effective September 24, 2026.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669637184","title":"Medtide Inc. - Intends to Further Integrate Adjacent Land Parcel in Phase Ii to Develop Large-Scale CDMO Production Park, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2669637184","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669637184?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:48","pubTimestamp":1790239734,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182821218","title":"Medtide Inc. Interim 2026: Revenue Slips 7.6%, Profit Halves on Order Deferrals and FX Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=1182821218","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182821218?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:47","pubTimestamp":1790239669,"startTime":"0","endTime":"0","summary":"Medtide Inc. released its 2026 interim results, reporting revenue of RMB 234.52 million, a 7.6% year-on-year decline caused largely by delayed deliveries that shifted portions of customer orders into...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Medtide Inc. Interim 2026: Revenue Slips 7.6%, Profit Halves on Order Deferrals and FX Losses","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463441","title":"Medtide - Li Lingmei Resigns as Executive Director Effective September 24, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463441?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:44","pubTimestamp":1790239455,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669314618","title":"Precision Peptide Becomes Strategic Sponsor of Championing Mental Health 3 Boxing Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2669314618","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669314618?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:03","pubTimestamp":1790075004,"startTime":"0","endTime":"0","summary":"Precision Peptide becomes strategic sponsor of Championing Mental Health 3 boxing eventThe Precision Peptide Company will sponsor Championing Mental Health 3 boxing event on Sept. 26, 2026 in Commerce","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL3TrmWF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322134","title":"Precision Peptide Starts U.S. Testing of Thymosin Alpha-1 Transdermal Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322134","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322134?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:04","pubTimestamp":1788865487,"startTime":"0","endTime":"0","summary":"Precision Peptide starts U.S. testing of Thymosin Alpha-1 transdermal patchThe Precision Peptide Company started formal U.S. testing of a Thymosin Alpha-1 transdermal patch, targeting completion in Q3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc8w6w6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662095636","title":"Medtide (SEHK:3880) Stock Drifts As Margin Gains Meet Revenue Reset","url":"https://stock-news.laohu8.com/highlight/detail?id=2662095636","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662095636?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:33","pubTimestamp":1787916832,"startTime":"0","endTime":"0","summary":"Medtide shares have drifted lower over the past week and month, yet the latest half year earnings land with a very different message. The headline is margin power. Net profit margin over the last 12 months is 30.7%, compared with 22.2% a year earlier, while earnings per share on that same basis sit at 1.19 CNY. The stock closed at HK$21.5 on a trailing P/E of 15.5x, which leaves today’s muted price reaction at odds with the profitability story Medtide just put on the table.\nLove Medtide’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-stock-drifts-as-margin-gains-meet-revenue-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-stock-drifts-as-margin-gains-meet-revenue-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","JOYT","03880","VOTE","VGFPF","FEBU","BK1141","PMDE","GXDW","RGLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158944843","title":"MEDTIDE Proposes Adoption of Restricted Share Unit Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1158944843","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158944843?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:52","pubTimestamp":1787820762,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) announced that on August 27, 2026, its board of directors passed resolutions concerning the proposed adoption of a restricted share unit scheme and the proposed adoption of a service...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128983823","title":"MEDTIDE Posts 47.4% Drop in Net Profit for Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1128983823","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128983823?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:41","pubTimestamp":1787820096,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has released its interim results for 2026, reporting revenue of approximately RMB 235 million, a year-on-year decrease of 7.6%. Gross profit stood at around RMB 136 million, down...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774375","title":"Medtide Proposes Bylaw Changes to Allow Board Size Range of Five to Nine Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774375","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774375?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:40","pubTimestamp":1787820000,"startTime":"0","endTime":"0","summary":"Medtide proposes bylaw changes to allow board size range of five to nine directorsMedtide unveiled bylaw changes covering its Articles of Association plus board and shareholder-meeting procedure rules","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL2FjHyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748347","title":"Medtide Proposes 10-Year RSU Incentive Scheme with 14,180,000-Share Mandate Limit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748347","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748347?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:35","pubTimestamp":1787819708,"startTime":"0","endTime":"0","summary":"Medtide proposes 10-year RSU incentive scheme with 14,180,000-share mandate limitMedtide set plans to adopt a 2026 RSU Scheme, subject to shareholder approval at an extraordinary general meeting.Schem","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL5TZL4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662747771","title":"Medtide Hy Revenue Rmb234.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662747771","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662747771?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:32","pubTimestamp":1787819534,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXL0Q8SQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771718","title":"Medtide H1 FY26 Profit Drops 47.4% to RMB 53.68 Million; Revenue Falls 7.6% to RMB 234.52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771718","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771718?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:31","pubTimestamp":1787819477,"startTime":"0","endTime":"0","summary":"Medtide H1 FY26 profit drops 47.4% to RMB 53.68 million; revenue falls 7.6% to RMB 234.52 millionMedtide posted IFRS profit attributable to owners of the parent of RMB 53.68 million, down 47.4% year o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL2y4PHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473224","title":"Precision Peptide Develops Needle-Free Tirzepatide Transdermal Patch in U.S","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473224","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473224?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:04","pubTimestamp":1787137449,"startTime":"0","endTime":"0","summary":"Precision Peptide develops needle-free tirzepatide transdermal patch in U.SThe Precision Peptide Company is developing a needle-free tirzepatide transdermal patch in the U.S. as an expansion of its de","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL4zwmm5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660124483","title":"Medtide Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660124483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660124483?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:34","pubTimestamp":1786955640,"startTime":"0","endTime":"0","summary":"Medtide schedules board meeting to review interim resultsMedtide will hold a board meeting on Aug. 27, 2026 to consider interim results for the six months ended June 30, 2026.Disclaimer:This news brie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL6Gc7j2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119829447","title":"Hong Kong Stock CXO Sector Rallies; Will MEDTIDE (03880) Defy the Trend or Bounce Back After Its Profit Warning?","url":"https://stock-news.laohu8.com/highlight/detail?id=1119829447","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119829447?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:26","pubTimestamp":1786069600,"startTime":"0","endTime":"0","summary":" On July 31, after the market close, MEDTIDE (03880) issued a profit warning for its 26H1 fiscal year. The company expects period revenue of approximately RMB 229.8-239.2 million, a year-over-year...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","WX","CXO","BK4588","KCAI","NIFE","03880","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544565","title":"Cpc Scientific Announces U.S. FDA Pre-License Inspection (Pli) Successfully Completed at Its Hangzhou Cgmp Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent Bla Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544565?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:11","pubTimestamp":1785931860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA7VZCWP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150516282","title":"Medtide Posts Steady July 2026 Share Capital; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1150516282","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150516282?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:29","pubTimestamp":1785922152,"startTime":"0","endTime":"0","summary":"Medtide Inc. filed its Monthly Return for Equity Issuer for the period ended 31 July 2026, confirming that the company’s share structure remained unchanged throughout the month. • Authorised/Issued...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medtideinc.com","stockEarnings":[{"period":"1week","weight":0.1048},{"period":"1month","weight":0.0373},{"period":"3month","weight":0.0289},{"period":"6month","weight":0.0152},{"period":"1year","weight":-0.257},{"period":"ytd","weight":-0.2526}],"compareEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.0446},{"period":"3month","weight":0.0811},{"period":"6month","weight":-0.0177},{"period":"1year","weight":-0.0746},{"period":"ytd","weight":-0.0437}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.","exchange":"SEHK","name":"MEDTIDE","nameEN":"MEDTIDE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MEDTIDE(03880) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MEDTIDE,03880,MEDTIDE股票,MEDTIDE股票老虎,MEDTIDE股票老虎国际,MEDTIDE行情,MEDTIDE股票行情,MEDTIDE股价,MEDTIDE股市,MEDTIDE股票价格,MEDTIDE股票交易,MEDTIDE股票购买,MEDTIDE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MEDTIDE(03880),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MEDTIDE(03880) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}